Regulatory guidance for diabetes tech
A collection of guidance has been published by the Medicines and Healthcare products Regulatory Agency (MHRA) to update manufacturers of medical devices on new regulations.
A collection of guidance has been published by the Medicines and Healthcare products Regulatory Agency (MHRA) to update manufacturers of medical devices on new regulations.
Beta Bionics, developer of an automated insulin delivery system, has recently filed for an initial public offering. The company has not disclosed the number of
Dexcom’s CEO Kevin Sayer has shared new data on the company’s first over-the-counter glucose sensor at the recent J.P. Morgan Healthcare Conference in America earlier
The US Food and Drug Administration (FDA) has cleared the Abbott Libre 2 and 3 continuous glucose monitoring (CGM) sensors for use during most imaging
Medtronic has announced plans to submit its MiniMed 780G for an expanded indication from the FDA for Type 2 diabetes in the first half of
A new analysis of real-world data has found that the use of continuous glucose monitoring (CGM) reduces the risk for hospitalization and improves glucose control
Apple has revealed plans to add sleep apnoea notifications to its smartwatch this month, equipping the device to detect breathing disturbances. There is a link
One US doctor has reported that CGM usage can help patients through a “carrot and stick” approach to dieting. Eating foods known to cause weight
Senseonics and its commercial partner Ascensia Diabetes Care have received clearance from the Food and Drug Administration for the first implantable glucose sensor that can
Beta Bionics has announced that it has partnered with Abbott (NYSE:ABT) to integrate the company’s CGM with its automated insulin delivery system. The companies plan